LoginRegister
    Abbott, Australian Blood Service ink agreement for Alinity SystemAbbott, Australian Blood Service ink agreement for Alinity System
    Crown Bioscience launches patient-derived tumour organoid drug development platformCrown Bioscience launches patient-derived tumour organoid drug development platform
    Medical Devices classified as Drugs: CDSCO releases Amendment Rules for registeration of 36 devicesMedical Devices classified as Drugs: CDSCO releases Amendment Rules for registeration of 36 devices
    Alembic Pharma JV gets USFDA approval for Desonide Ointment to treat skin diseasesAlembic Pharma JV gets USFDA approval for Desonide Ointment to treat skin diseases
    New batch of Strides Pharma Ranitidine available for sale in AustraliaNew batch of Strides Pharma Ranitidine available for sale in Australia
    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophreniaCadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia
    Major US retailers including Walmart pull bottles of JnJ baby powder from shelvesMajor US retailers including Walmart pull bottles of JnJ baby powder from shelves
    Reckitt Benckiser to pay USD 700 million to settle opioid probesReckitt Benckiser to pay USD 700 million to settle opioid probes
    Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; DetailsDrug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality;...
    GSK ovarian cancer drug Zejula gets USFDA nod for wider useGSK ovarian cancer drug Zejula gets USFDA nod for wider use
    Strides Pharma clears USFDA inspection of Alathur facilityStrides Pharma clears USFDA inspection of Alathur facility
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurityDr Reddys recalls Ranitidine products in US over cancer-causing impurity
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X